SEC v. Gannon Giguiere; Oliver-Barret Lindsay; Kevin Gillespie; Annetta Budhu; and Andrew Hackett, No. LR-24201, Southern District of California (July 16, 2018) — Press Release

SEC Files Charges in Busted Microcap Schemes Litigation Release No. 24201 / July 16, 2018 Securities and Exchange Commission v. Gannon Giguiere et al., No. 3:18-cv-01530 (S.D. Ca. filed July 6, 2018) The Securities and Exchange Commission has charged a stock promoter and four others involved in an alleged series of microcap fraud schemes that were foiled by FBI undercover work and an SEC trading suspension. According to the SEC's complaint filed in federal court in southern California on July 6, stock promoter Gannon Giguiere took control of a purported medical device company. Giguiere, together with a Cayman Islands-based broker, then allegedly engaged in a matched trading scheme that caused the company's share price to rise from zero to $1.20 per share. Giguiere and the brokerage owner, Oliver-Barret Lindsay, allegedly coordinated their matched trading through an individual who turned out to be an FBI cooperating witness. According to the complaint, despite extensive encrypted communications, the defendants were caught by an undercover FBI operation that recorded their communications, with Lindsay going so far as to tell an individual cooperating with the FBI, "I'm a little hesitant about typing all of these details into this app. ¢€¦ You can just imagine if it finds its way somewhere it's fairly incriminating." According to the complaint, the pair's plan to dump millions of shares in the purported medical device company was thwarted when, this past March, the SEC suspended trading in the securities of the purported medical device company. The SEC's complaint also charges three others who began laying the groundwork for a pump-and-dump scheme involving a purported digital media company. The SEC alleges that Kevin Gillespie, Annetta Budhu, and Andrew Hackett entered into a number of sham stock and debt issuances, and Hackett wound up communicating with someone he believed to be a participant in the scheme who in reality was an undercover FBI agent. The U.S. Attorney's Office for the Southern District of California has announced criminal charges in the case. The SEC's complaint, filed in U.S. District Court in the Southern District of California, charges Giguiere, Lindsay, Hackett, Gillespie, and Budhu with violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The SEC seeks permanent injunctions, disgorgement, penalties, penny stock bars, and officer-and-director bars against Giguiere and Gillespie. The SEC's investigation, which is continuing, has been conducted by John O. Enright, Joseph P. Ceglio, Diego Brucculeri, and Sheldon L. Pollock of the New York office. The case is being supervised by Sanjay Wadhwa. The SEC appreciates the assistance of the FBI, U.S. Attorney's Office for the Southern District of California, and the Financial Industry Regulatory Authority. SEC Complaint

SEC Files Charges in Busted Microcap Schemes Litigation Release No. 24201 / July 16, 2018 Securities and Exchange Commission v. Gannon Giguiere et al., No. 3:18-cv-01530 (S.D. Ca. filed July 6, 2018) The Securities and Exchange Commission has charged a stock promoter and four others involved in an alleged series of microcap fraud schemes that were foiled by FBI undercover work and an SEC trading suspension. According to the SEC's complaint filed in federal court in southern California on July 6, stock promoter Gannon Giguiere took control of a purported medical device company. Giguiere, together with a Cayman Islands-based broker, then allegedly engaged in a matched trading scheme that caused the company's share price to rise from zero to $1.20 per share. Giguiere and the brokerage owner, Oliver-Barret Lindsay, allegedly coordinated their matched trading through an individual who turned out to be an FBI cooperating witness. According to the complaint, despite extensive encrypted communications, the defendants were caught by an undercover FBI operation that recorded their communications, with Lindsay going so far as to tell an individual cooperating with the FBI, "I'm a little hesitant about typing all of these details into this app. ¢€¦ You can just imagine if it finds its way somewhere it's fairly incriminating." According to the complaint, the pair's plan to dump millions of shares in the purported medical device company was thwarted when, this past March, the SEC suspended trading in the securities of the purported medical device company. The SEC's complaint also charges three others who began laying the groundwork for a pump-and-dump scheme involving a purported digital media company. The SEC alleges that Kevin Gillespie, Annetta Budhu, and Andrew Hackett entered into a number of sham stock and debt issuances, and Hackett wound up communicating with someone he believed to be a participant in the scheme who in reality was an undercover FBI agent. The U.S. Attorney's Office for the Southern District of California has announced criminal charges in the case. The SEC's complaint, filed in U.S. District Court in the Southern District of California, charges Giguiere, Lindsay, Hackett, Gillespie, and Budhu with violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder. The SEC seeks permanent injunctions, disgorgement, penalties, penny stock bars, and officer-and-director bars against Giguiere and Gillespie. The SEC's investigation, which is continuing, has been conducted by John O. Enright, Joseph P. Ceglio, Diego Brucculeri, and Sheldon L. Pollock of the New York office. The case is being supervised by Sanjay Wadhwa. The SEC appreciates the assistance of the FBI, U.S. Attorney's Office for the Southern District of California, and the Financial Industry Regulatory Authority. SEC Complaint